Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chromatin status and transcriptomics of HEK293, U2OS, HepG2 and K562

ABSTRACT: Chromatin status and transcriptomics of HEK293, U2OS, HepG2 and K562

PROVIDER: PRJNA578731 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10319900.fastq.gz	Fastqsanger.gz
	SRR10319901.fastq.gz	Fastqsanger.gz
	SRR10319902.fastq.gz	Fastqsanger.gz
	SRR10319903.fastq.gz	Fastqsanger.gz
	SRR10319904.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Chromatin status and transcriptomics of HEK293, U2OS, HepG2 and K562

Project description:RNA-seq, H3K27Ac ChIP-seq, and ATAC-seq data of U2OS, HEK293, HepG2, and K562 cell lines

2020-12-31 | GSE139190 | GEO

Glucocorticoid receptor profiling in IMR90,K562 and U2OS (ChIP-seq)

Project description:To identify the sequences responsible for recruitment of Glucocorticoid receptor (GR) to individual loci, we performed ChIP-seq and ChIP-exo that combines chromatin immunoprecipitation with an exonuclease digestion step. We performed these experiments in three cell lines : IMR90 (ATTC:CCL-186), U2OS osteosarcoma cell lines, K562 (ATCC:CCL243), upon glucocorticoid treatment. The U2OS assays are the same as those in E-MTAB-2731.

2015-02-25 | E-MTAB-2955 | biostudies-arrayexpress

Ribo-seq on K562 and HepG2 cells

Project description:Ribo-seq on K562 and HepG2 cells

| PRJNA529885 | ENA

Glucocorticoid receptor profiling in IMR90, K562 and U2OS (ChIP-exo)

2015-02-25 | E-MTAB-2956 | biostudies-arrayexpress

RNA-Seq of wild-type HEK293 and K562 celllines

Project description:RNA-Seq of wild-type HEK293 and K562 celllines

| PRJEB7858 | ENA

Glucocorticoid receptor profiling in IMR90,K562 and U2OS (ChIP-seq)

Project description:Glucocorticoid receptor profiling in IMR90,K562 and U2OS (ChIP-seq)

| PRJEB7372 | ENA

Glucocorticoid receptor profiling in IMR90, K562 and U2OS (ChIP-exo)

Project description:Glucocorticoid receptor profiling in IMR90, K562 and U2OS (ChIP-exo)

| PRJEB7365 | ENA

U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2

Project description:U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2 Keywords: other

2005-04-06 | GSE2292 | GEO

RNA-sequencing data of TIP60 mutated and control U2OS cells

Project description:In this study we examined the effects of loss of the MYST histone acetyltransferase TIP60 (KAT5) in mouse embryonic fibroblasts (MEFs), human embryonic kidney cells 293 (HEK293), and human osteosarcoma cells (U2OS) on cell proliferation, BrdU incorporation, cell cycle progression, apoptotic and other forms of cell death, DNA damage, histone acetylation at specific lysine residues and RNA expression levels. This dataset relates to U2OS cells. To assess the effects of loss of TIP60 on RNA levels, RNA-seq was performed on U2OS cells, where the TIP60 gene was mutated by CRISPR/Cas9 technology using single guide RNA #1 (g1/C9), single guide RNA #2 (g2/C9), or guide-only controls (g1 or g2). The expression of the guide RNA was induced with doxycycline treatment for 4 days to induce TIP60 gene mutation in the samples also expressing the Cas9 enzyme.

2022-07-22 | GSE208382 | GEO

Whole-genome CRISPR screen of etoposide-treated U2OS and U2OS p53KO cells, and RNAseq of U2OS cells incubated in media conditioned by etoposide-treated U2OS or U2OS p53KO cells.

Project description:CRISPR screen: U2OS or U2OS p53KO cells expressing Cas9 were transduced with a whole-genome library of CRISPR sgRNAs, then treated with either DMSO or etoposide. Differential sgRNA abundances were calculated for each condition and used to determine the effect of each single gene knockout on fitness and the drug-induced death rate. RNA-Seq: U2OS or U2OS p53KO cells were cultured with either DMSO or etoposide for 48 hours, and then U2OS cells were incubated in this conditioned media for 8 hours. RNA was collected and use to observe differential expression changes between conditions.

2023-05-17 | GSE232592 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data